CNC Centene Corporation Common Stock
$63.96
价格 · 八月 20, 2026
截至...的财报数据 七月 28, 2026
52周区间
$28–$69
87% of range
分析师评级
HOLD
27 analysts
目标价
$72
+12% upside
P/E (TTM)
-6.0
ROE
-28.8%
净利润率
-3.4%
关于 Centene Corporation Common Stock 公司概况（来自维基百科）
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
阅读更多
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
History
Centene was founded by Elizabeth Brinn as Managed Health Services in Milwaukee, Wisconsin, in 1984. After the death of Brinn, the non-profit organization was sold to investors. The proceeds went to the Betty Brinn Foundation, which became a major shareholder in Centene. In 1996, Michael Neidorff joined the company as chief executive.
Centene went public in December 2001. In 2006, the firm acquired US Script, a pharmacy benefits manager. The company later merged US Script with subsidiaries to form its Envolve divisions. In 2011, the firm formed Centurion, a provider of correctional health care services, as a joint venture with MHM Services. In 2018, it acquired MHM Services, including its stake in Centurion. Centene began offering state-run Medicaid programs through Affordable Care Act exchanges in 2014.
In July 2015, Centene announced it would acquire Health Net and Trillium Community Health Plan (serving Oregon). In March 2016, it finalized its acquisition. In September 2017, it announced that it would acquire Fidelis Care, a nonprofit insurer in New York, for US$3.75 billion. In March 2019, it announced plans to acquire WellCare for US$17.3 billion. In January 2021, it was announced that it would acquire Magellan Health for $2.2 billion. In January 2022, the acquisition was completed.
In the United Kingdom, Centene began to acquire local healthcare services in 2017. In 2019, Centene, through its subsidiary MH Services, took a 40% stake in Circle Health, as part of a deal which created a national network of over 50 private hospitals. Centene gained full control of Circle Health in July 2021, and sold the business to PureHealth in August 2023.
In early 2021, Operose Health, a UK subsidiary of Centene, took over a group of London practices, AT Medics.
In May 2022, Centene sold off its pharmacy benefit management businesses, Magellan Rx and PANTHERx Rare, for a total of $2.8 billion.
Business segments
The main lines of Centene include:
Medicaid
Arizona Complete Health
Arkansas Total Care
Health Net (California)
Delaware First Health
Sunshine Health (Florida)
Peach State Health Plan (Georgia)
'Ohana Health Plan (Hawaii)
Meridian (Illinois and Michigan)
Managed Health Care Services (Indiana)
Iowa Total Care
Sunflower Health Plan (Kansas)
WellCare of Kentucky
Louisiana Healthcare Connections
Magnolia Health (Mississippi)
Home State Health Plan (Missouri)
Nebraska Total Care
SilverSummit Healthplan (Nevada)
NH Healthy Families (New Hampshire)
Fidelis Care (New Jersey, New York)
Carolina Complete Health (North Carolina)
WellCare of North Carolina
Buckeye Health Plan (Ohio)
Oklahoma Complete Health
Trillium Community Health Plan (Oregon)
PA Health & Wellness (Pennsylvania)
Absolute Total Care (South Carolina)
Superior HealthPlan (Texas)
Coordinated Care (Washington)
MHS Health Wisconsin
ACA health insurance marketplace - Ambetter
Arkansas Health & Wellness
Celtic Insurance Company
WellCare of New Jersey
Medicare
WellCare
Allwell
Correctional healthcare - Centurion
Commercial insurance
QualChoice (Arkansas)
Health Net (California, Oregon)
Behavioral health - Magellan Health
Leaders
In 2020, CEO Michael Neidorff's compensation of nearly $25 million made him the highest-paid healthcare executive in the United States.
In December 2021, Politan Capital Management took a $900 million stake in Centene. Weeks later, Neidorff announced plans to retire within a year. He actually stepped down in March 2022.
He was replaced by Sarah London.
Controversies
In 2014, Fox News alleged that Superior HealthPlan of Texas denied coverage of an infant's surgery for brain cancer at Texas Children's Hospital. Superior HealthPlan is a joint venture of Centene and Community Health Centers Network LP, which provides services for Medicaid recipients. The article reported that Superior HealthPlan had previously paid healthcare claims for the infant at the hospital, although Superior HealthPlan stated that it did not cover procedures at the facility. Three days after the article was published, Superior HealthPlan reversed its decision and covered the surgery.
In January 2018, a class action lawsuit accused Centene's Ambetter marketplace healthcare plans of misleading enrollees about plan benefits. According to the lawsuit, people who bought Centene's plans had difficulty finding medical providers that accepted patients covered under Centene's policies.
In December 2018, Centene was sued by two pension funds alleging that Centene's acquisition of Health Net resulted in damages to Centene and exposed the company to potential liability. The suit also alleged that Centene concealed that Health Net owed approximately $1B in past tax liabilities to California and was under investigation for Medicare fraud at the time of the acquisition.
In 2022, Operose Health had almost 600,000 NHS patients and was the largest supplier of GP services to the NHS. It was accused of putting patients at risk by prioritising profit, specifically by hiring physician associates, because they were cheaper than GPs. At Operose practices the average number of full time equivalent GPs per patients is about half the average in English practices. Sir Sam Everington said he was worried to see physician associates saying they were not receiving the supervision they needed. The practice had a backlog of thousands of medical test results and hospital letters on their computer systems. Operose said 97% of its practices were rated "good" or "outstanding" by the Care Quality Commission.
In April of 2026, Centene Corporation reportedly ended coverage of hormone replacement therapy for transgender patients in its Ambetter Insurance medicare and medicaid plans across 19 states without informing customers.
Settlements
In April 2021, Health Net Federal Services, a subsidiary of Centene, agreed to pay $97M to settle allegations that it had duplicated or inflated claims submitted to the Department of Veterans Affairs.
Between June 2021 and January 2022, Centene agreed to settlements with several states on behalf of their subsidiary, Envolve, a pharmacy benefit manager, including Ohio, Mississippi, Illinois, Arkansas, and New Hampshire to resolve allegations of overpayments to the PBM from the states' Medicaid programs. The settlements have totaled over $191 million.
In December 2021, Centene agreed to pay $27.6M to Kansas to settle allegations that it had failed to disclose discounts and used other strategies to obtain more profit from Kansas' Medicaid program.
In September 2022, Centene will pay more than $14 million to Massachusetts's to resolve claims that it overcharged the state Medicaid program, MassHealth, millions of dollars for pharmacy benefits and services provided by subsidiary companies.
Centene overbilled Florida $67 million in 2021 and proactively notified the state. Their discussions with Agency for Health Care Administration (AHCA) ended in 2024 and Centene agreed to return the $67 million. $10 million of that was sent to Hope Florida Foundation, rather than the state directly.
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
CNC 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$63.95
市值
$40.00B
P/E (TTM)
-6.0
每股收益 (TTM)
$-13.53
营收 (TTM)
$194.78B
股息收益率
—
ROE
-28.8%
负债/权益
0.9
52周区间
$28 – $69
CNC 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$194.78B
2016-12-31
→
2025-12-31
EPS
$-13.53
2016-12-31
→
2025-12-31
自由现金流
$4.32B
2016-12-31
→
2025-12-31
利润率
-3.4%
2023-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CNC
同行中位数
P/E (TTM)
-6.0
35.0
P/S (TTM) (市销率 (TTM))
0.2
0.9
P/B (市净率)
2.0
3.5
EV / EBITDA (企业价值 / EBITDA)
-4.9
—
Price / FCF (股价/自由现金流)
9.3
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CNC
同行中位数
Gross Margin (毛利率)
7.3%
12.9%
Operating Margin (营业利润率)
-3.9%
—
Net Profit Margin (净利润率)
-3.4%
0.89%
ROA
-8.4%
3.5%
ROE
-28.8%
10.1%
ROIC
-20.2%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CNC
同行中位数
Debt / Equity (负债/股东权益比率)
0.9
—
Current Ratio (流动比率)
1.1
1.6
Quick Ratio (速动比率)
0.6
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CNC
同行中位数
Revenue YoY (营收同比增长)
19.4%
—
Revenue CAGR 3Y (营收3年复合年增长率)
10.4%
—
Revenue CAGR 5Y (营收5年复合年增长率)
11.9%
—
EPS YoY
27.5%
—
Net Income YoY (净利润同比增长)
22.3%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CNC
同行中位数
CNC 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
27 位分析师
- 强烈买入 4 14.8%
- 买入 7 25.9%
- 持有 15 55.6%
- 卖出 1 3.7%
- 强烈卖出 0 0.0%
12个月价格目标
18 位分析师 · 2026-08-20
中位数
$70.50
现在
$63.95
最低
$56.00
最高
$85.00
中位数目标
$70.50
+10.2%
平均目标
$71.67
+12.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.44%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $2.51 | $1.10 | 1.4% |
| 2026年3月31日 | $3.37 | $2.15 | 1.2% |
| 2025年12月31日 | $-1.19 | $-1.24 | 0.05% |
| 2025年9月30日 | $0.50 | $-0.14 | 0.64% |
| 2025年6月30日 | $-0.16 | $0.87 | -1.0% |
| 2025年3月31日 | $2.90 | $2.57 | 0.33% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Cost of Revenue | $2.67B | $2.73B | $3.56B | $7.03B | $4.89B | $3.30B | $2.46B | $2.39B | $1.85B | $1.86B | $1.62B | $1.28B | |
| Gross Profit | $14.21B | $17.07B | $17.64B | $16.92B | $14.49B | · | · | · | · | · | · | · | |
| SG&A Expense | $12.90B | $12.40B | $12.56B | $11.59B | $9.60B | $9.38B | $6.53B | $6.04B | $4.45B | $3.67B | $1.80B | $1.30B | |
| Operating Expenses | $202.40B | $159.90B | $151.07B | $143.23B | $124.20B | $108.03B | $72.86B | $58.66B | $47.18B | $39.34B | $22.05B | $16.10B | |
| Operating Income | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M | |
| Interest Expense | · | · | $725M | $665M | $665M | $728M | $412M | $343M | $255M | $217M | $43M | $35M | |
| Other Non-op | $895M | $1.08B | $668M | $644M | · | · | · | · | · | · | · | · | |
| Pretax Income | $-6.73B | $4.26B | $3.60B | $1.96B | $1.81B | $2.77B | $1.78B | $1.37B | $1.13B | $1.16B | $697M | $457M | |
| Income Tax | $-51M | $963M | $899M | $760M | $477M | $979M | $473M | $474M | $326M | $599M | $339M | $196M | |
| Net Income | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| EPS (Basic) | $-13.53 | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 | $1.76 | $2.98 | $2.33 | |
| EPS (Diluted) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 | $3.12 | $3.14 | $2.26 | $2.34 | $1.71 | $2.88 | $2.25 | |
| Shares (Basic) | 493,116,000 | 521,790,000 | 543,319,000 | 575,191,000 | 582,832,000 | 570,722,000 | 413,487,000 | 390,248,000 | 344,853,000 | 319,135,000 | 119,101,000 | 116,345,764 | |
| Shares (Diluted) | 493,116,000 | 523,744,000 | 545,704,000 | 582,040,000 | 590,516,000 | 579,135,000 | 420,409,000 | 398,506,000 | 353,404,000 | 327,951,000 | 123,066,000 | 120,360,212 | |
| EBITDA | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.89B | $14.06B | $17.19B | $12.07B | $13.12B | $10.80B | $12.12B | $5.34B | $4.07B | $3.93B | $1.76B | $1.61B | |
| Short-term Investments | $2.43B | $2.62B | $2.46B | $2.32B | $1.54B | $1.58B | $863M | $722M | $531M | $505M | $176M | $177M | |
| Other Current Assets | $1.95B | $1.60B | $5.57B | $2.46B | $1.60B | $1.32B | $1.09B | $784M | $687M | $715M | $390M | $252M | |
| Current Assets | $40.37B | $38.00B | $40.76B | $30.13B | $28.50B | $23.39B | $20.32B | $12.00B | $8.70B | $8.37B | $3.60B | $2.95B | |
| PP&E (Net) | $2.04B | $2.07B | $2.02B | $2.43B | $3.39B | $2.77B | $2.12B | $1.71B | $1.10B | $797M | $518M | $445M | |
| PP&E (Gross) | $4.27B | $4.87B | $4.42B | $4.50B | $5.29B | $4.25B | $3.22B | $2.51B | $1.69B | $1.24B | $869M | $733M | |
| Accum. Depreciation | $2.23B | $2.80B | $2.40B | $2.07B | $1.90B | $1.48B | $1.10B | $800M | $590M | $442M | $351M | $288M | |
| Goodwill | $10.84B | $17.56B | $17.56B | $18.81B | $19.77B | $18.65B | $6.86B | $7.01B | $4.75B | $4.71B | $842M | $754M | |
| Intangibles | $4.53B | $5.41B | $6.10B | $6.91B | $7.82B | $8.39B | $2.06B | $2.24B | $1.40B | $1.54B | $155M | $120M | |
| Other Non-current Assets | $528M | $593M | $535M | $2.69B | $3.78B | $1.60B | $1.25B | $527M | $454M | $95M | $177M | $174M | |
| Total Assets | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Accounts Payable | $13.80B | $13.17B | $16.42B | $9.53B | $8.49B | $7.07B | $4.16B | $4.05B | $4.17B | $3.76B | $976M | $768M | |
| Current Liabilities | $36.72B | $34.26B | $36.72B | $28.46B | $25.77B | $21.59B | $12.93B | $11.97B | $9.33B | $8.62B | $3.63B | $2.90B | |
| Capital Leases | $615M | $738M | $880M | $3.13B | $3.62B | $1.33B | $622M | · | · | · | · | · | |
| Deferred Tax | $833M | $684M | $641M | $615M | $1.41B | $1.53B | $189M | · | · | · | · | · | |
| Other Non-current Liabilities | $1.79B | $2.57B | $3.62B | $5.62B | $5.61B | $2.96B | $1.54B | $1.26B | $952M | $869M | $170M | $159M | |
| Total Liabilities | $56.69B | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B | $14.14B | $5.01B | $3.93B | |
| Long-term Debt | $17.49B | $18.64B | $17.96B | $18.18B | $19.03B | $16.88B | $13.86B | $6.85B | $4.83B | $4.78B | $1.22B | $878M | |
| Total Debt | $17.40B | $18.53B | $17.83B | $18.02B | $18.84B | $16.78B | $13.73B | $6.69B | $4.70B | $4.66B | $1.22B | $893M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $8.67B | $15.35B | $12.04B | $9.34B | $8.14B | $6.79B | $4.98B | $3.66B | $2.75B | $1.92B | $1.36B | $1.00B | |
| Treasury Stock | $9.44B | $9.00B | $5.86B | $4.21B | $1.09B | $816M | $214M | $139M | $244M | $179M | $147M | $98M | |
| AOCI | $-58M | $-504M | $-652M | $-1.13B | $77M | $337M | $134M | $-56M | $-3M | $-36M | $-10M | $-1M | |
| Stockholders' Equity | $19.95B | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B | $5.89B | $2.16B | $1.74B | |
| Liabilities + Equity | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Shares Outstanding | 491,757,000 | 620,195,000 | 615,291,000 | 607,847,000 | 602,704,000 | 598,249,000 | 421,508,000 | 417,695,000 | 360,758,000 | 356,268,000 | 253,710,000 | 124,275,000 |
现金流 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.27B | $1.24B | $1.29B | $1.43B | $1.33B | $1.26B | $643M | $495M | $361M | $278M | $111M | $89M | |
| Stock-based Comp | $204M | $212M | $216M | $234M | $203M | $281M | $177M | $145M | $135M | $148M | $71M | $48M | |
| Deferred Tax | $-60M | $13M | $-78M | $-631M | $-132M | $-51M | $55M | $-129M | $-108M | $92M | $-17M | $-42M | |
| Amort. of Intangibles | $685M | $692M | $718M | $817M | $770M | $719M | $258M | $211M | $156M | $147M | $24M | $16M | |
| Operating Cash Flow | $5.09B | $154M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B | $1.85B | $658M | $1.22B | |
| CapEx | $767M | $644M | $799M | $1.00B | $910M | $869M | $730M | $675M | $422M | $306M | $150M | $103M | |
| Investing Cash Flow | $472M | $-1.05B | $-1.19B | $-2.92B | $-3.30B | $-6.96B | $-1.53B | $-4.58B | $-1.25B | $-2.47B | $-813M | $-848M | |
| Debt Issued | $750M | $1.30B | $2.33B | $360M | $9.27B | $5.11B | $24.72B | $6.08B | $1.40B | $8.95B | $1.93B | $1.88B | |
| Net Debt Issued | $-1.15B | $678M | $19M | $-1.13B | $1.83B | $1.04B | $6.92B | $1.99B | $47M | $2.87B | $342M | $201M | |
| Stock Issued | $37M | $46M | $44M | $70M | $35M | $28M | $0 | $2.78B | $0 | $0 | · | · | |
| Stock Repurchased | $475M | $3.12B | $1.63B | $3.10B | $297M | $626M | $75M | $71M | $65M | $63M | $53M | $29M | |
| Net Stock Activity | $-438M | $-3.08B | $-1.59B | $-3.03B | $-297M | $-626M | $-75M | $2.71B | $-65M | $-63M | $-53M | $-29M | |
| Financing Cash Flow | $-1.62B | $-2.41B | $-1.66B | $-4.20B | $1.36B | $260M | $6.83B | $4.61B | $-82M | $2.72B | $305M | $198M | |
| Net Change in Cash | $3.94B | $-3.30B | $5.17B | $-868M | $2.26B | $-1.17B | $6.78B | $1.26B | $153M | $2.10B | $150M | $572M | |
| Taxes Paid | $448M | $1.00B | $887M | $1.20B | $678M | $1.19B | $612M | $448M | $496M | $556M | $328M | $237M | |
| Free Cash Flow | $4.32B | $-490M | $7.25B | $5.26B | $3.29B | $4.63B | $753M | $559M | $1.07B | $1.54B | $508M | $1.12B | |
| Levered FCF | · | · | $6.71B | $4.85B | $2.80B | $4.16B | $450M | $335M | $885M | $1.44B | $486M | $1.10B |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.3% | 10.5% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| Net Margin | -3.4% | 2.0% | 1.8% | 0.83% | 1.1% | 1.6% | 1.8% | 1.5% | 1.7% | 1.4% | 1.6% | 1.6% | |
| Pretax Margin | -3.5% | 2.6% | 2.3% | 1.4% | 1.4% | 2.5% | 2.4% | 2.3% | 2.3% | 2.9% | 3.1% | 2.8% | |
| EBITDA Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| ROA | -8.4% | 4.0% | 3.4% | 1.6% | 1.8% | 3.3% | 3.7% | 3.4% | 3.9% | 4.1% | 5.4% | 5.8% | |
| ROE | -28.8% | 12.7% | 10.8% | 4.7% | 5.1% | 9.4% | 11.3% | 10.1% | 13.0% | 14.0% | 18.2% | 18.2% | |
| ROIC | -20.2% | 5.5% | 5.0% | 1.9% | 2.9% | 4.7% | 5.0% | 5.4% | 7.4% | 5.8% | 10.7% | 10.1% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.6 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| Interest Coverage | · | · | 4.0 | 2.0 | 2.7 | 4.2 | 4.3 | 4.3 | 4.7 | 5.8 | 16.4 | 13.3 |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.4 | 2.0 | 1.9 | 1.9 | 1.7 | 2.0 | 2.1 | 2.3 | 2.3 | 2.9 | 3.5 | 3.5 |
增长率 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.4% | 5.9% | 6.5% | 14.7% | 13.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 27.5% | 139.1% | -9.2% | -26.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 40.4% | 16.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 22.3% | 124.8% | -10.8% | -25.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 34.9% | 14.3% | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Net Income TTM | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| Market Cap | $20.24B | $30.04B | $39.66B | $45.17B | $48.00B | $34.91B | $26.09B | $23.78B | $8.75B | $4.86B | $3.96B | $3.07B | |
| Enterprise Value | $17.32B | $31.89B | $37.84B | $48.79B | $52.18B | $39.31B | $26.83B | $24.40B | $8.84B | $5.08B | $3.24B | $2.24B | |
| P/E | -3.0 | 9.6 | 15.0 | 39.6 | 36.1 | 19.2 | 20.0 | 25.5 | 21.6 | 16.5 | 11.4 | 11.5 | |
| P/S | 0.1 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.2 | 0.1 | 0.2 | 0.2 | |
| P/B | 1.0 | 1.1 | 1.5 | 1.9 | 1.8 | 1.4 | 2.1 | 2.2 | 1.3 | 0.8 | 1.8 | 1.8 | |
| P / Tangible Book | 4.4 | 8.7 | 18.2 | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 4.0 | 195.1 | 4.9 | 7.2 | 11.4 | 6.3 | 17.6 | 19.3 | 5.9 | 2.6 | 6.0 | 2.5 | |
| P / FCF | 4.7 | -61.3 | 5.5 | 8.6 | 14.6 | 7.5 | 34.7 | 42.5 | 8.2 | 3.1 | 7.8 | 2.7 | |
| EV / EBITDA | -2.3 | 10.0 | 12.9 | 37.0 | 29.2 | 12.8 | 15.1 | 16.7 | 7.4 | 4.0 | 4.6 | 4.8 | |
| EV / FCF | 4.0 | -65.1 | 5.2 | 9.3 | 15.8 | 8.5 | 35.6 | 43.7 | 8.3 | 3.3 | 6.4 | 2.0 | |
| EV / Revenue | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Earnings Yield | -32.9% | 10.4% | 6.7% | 2.5% | 2.8% | 5.2% | 5.0% | 3.9% | 4.6% | 6.0% | 8.8% | 8.7% |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | $46.62B | $40.80B | $42.02B | $39.84B | $40.41B | $39.46B | $38.04B | $37.61B | $38.89B | $35.56B | $35.87B | |
| Cost of Revenue | $729M | $702M | $680M | $651M | $641M | $698M | $688M | $692M | $680M | $669M | $961M | $856M | $877M | $870M | $1.37B | $1.57B | |
| Gross Profit | $4.62B | $5.65B | $2.56B | $3.35B | $3.02B | $5.29B | $3.80B | $4.01B | $4.53B | $4.74B | $3.74B | $4.63B | $4.61B | $4.65B | $3.91B | $4.04B | |
| SG&A Expense | $3.10B | $3.40B | $3.37B | $3.15B | $3.04B | $3.35B | $3.23B | $3.06B | $2.89B | $3.22B | $3.49B | $3.05B | $3.02B | $3.01B | $3.20B | $2.85B | |
| Operating Expenses | $52.38B | $48.08B | $51.47B | $56.64B | $49.20B | $45.09B | $40.63B | $41.36B | $38.61B | $39.30B | $39.65B | $37.31B | $36.44B | $37.67B | $35.84B | $35.39B | |
| Operating Income | $1.20B | $1.86B | $-1.75B | $-6.95B | $-458M | $1.53B | $175M | $665M | $1.23B | $1.11B | $-194M | $735M | $1.17B | $1.22B | $-282M | $476M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $178M | · | $181M | $181M | $180M | · | $169M | |
| Other Non-op | $288M | $238M | $202M | $280M | $201M | $212M | $172M | $256M | $287M | $367M | · | · | · | · | · | · | |
| Pretax Income | $1.49B | $2.10B | $-1.54B | $-6.67B | $-257M | $1.75B | $347M | $921M | $1.52B | $1.47B | $24M | $768M | $1.42B | $1.39B | $41M | $1.01B | |
| Income Tax | $399M | $560M | $-443M | $-42M | $2M | $432M | $67M | $211M | $370M | $315M | $-15M | $293M | $360M | $261M | $260M | $269M | |
| Net Income | $1.09B | $1.54B | $-1.10B | $-6.63B | $-253M | $1.31B | $283M | $713M | $1.15B | $1.16B | $45M | $469M | $1.06B | $1.13B | $-213M | $738M | |
| EPS (Basic) | $2.21 | $3.13 | $-2.16 | $-13.50 | $-0.51 | $2.64 | $0.63 | $1.37 | $2.16 | $2.17 | $0.12 | $0.87 | $1.93 | $2.05 | $-0.37 | $1.29 | |
| EPS (Diluted) | $2.19 | $3.11 | $-2.15 | $-13.50 | $-0.51 | $2.63 | $0.63 | $1.36 | $2.16 | $2.16 | $0.12 | $0.87 | $1.92 | $2.04 | $-0.35 | $1.27 | |
| Shares (Basic) | 493,819,000 | 492,069,000 | -987,787,000 | 491,141,000 | 493,548,000 | 496,214,000 | -1,064,886,000 | 521,965,000 | 529,602,000 | 535,109,000 | -1,095,927,000 | 539,535,000 | 548,932,000 | 550,779,000 | -1,165,644,000 | 573,961,000 | |
| Shares (Diluted) | 497,637,000 | 495,591,000 | -989,753,000 | 491,141,000 | 493,548,000 | 498,180,000 | -1,068,613,000 | 523,542,000 | 530,755,000 | 538,060,000 | -1,099,719,000 | 541,270,000 | 550,308,000 | 553,845,000 | -1,172,869,000 | 580,607,000 | |
| EBITDA | $1.20B | $1.86B | · | $-6.95B | $-458M | $1.53B | · | $665M | $1.23B | $1.11B | · | $735M | $1.17B | $1.22B | · | $476M |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | $14.81B | $14.06B | $14.58B | $17.61B | $17.59B | $17.19B | $18.19B | $17.17B | $15.85B | $12.07B | $14.99B | |
| Short-term Investments | $2.91B | $2.48B | $2.43B | $2.18B | $2.77B | $2.47B | $2.62B | $2.99B | $2.61B | $2.08B | · | $2.24B | $2.21B | $2.13B | · | $2.19B | |
| Other Current Assets | $1.55B | $1.82B | $1.95B | $1.72B | $1.56B | $1.56B | $1.60B | $1.56B | $1.60B | $1.96B | · | $5.47B | $1.88B | $1.81B | · | $2.33B | |
| Current Assets | $46.69B | $44.99B | $40.37B | $44.06B | $40.39B | $41.29B | $38.00B | $37.41B | $38.41B | $38.45B | · | $41.41B | $34.87B | $35.01B | · | $33.27B | |
| PP&E (Net) | $2.13B | $2.09B | $2.04B | $2.16B | $2.12B | $2.04B | $2.07B | $2.04B | $2.04B | $1.99B | · | $2.00B | $2.42B | $2.48B | · | $2.48B | |
| PP&E (Gross) | · | · | $4.27B | · | · | · | $4.87B | · | · | · | · | · | · | · | · | $4.54B | |
| Accum. Depreciation | · | · | $2.23B | · | · | · | $2.80B | · | · | · | · | · | · | · | · | $2.06B | |
| Goodwill | $10.84B | $10.84B | $10.84B | $10.84B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $18.72B | $18.84B | $18.81B | $20.04B | |
| Intangibles | $4.20B | $4.36B | $4.53B | $4.84B | $5.01B | $5.24B | $5.41B | $5.58B | $5.75B | $5.93B | · | $6.28B | $6.52B | $6.73B | · | $7.52B | |
| Other Non-current Assets | $1.37B | $866M | $528M | $593M | $1.11B | $1.24B | $593M | $617M | $1.09B | $823M | · | $560M | $2.87B | $2.78B | · | $2.60B | |
| Total Assets | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Accounts Payable | $17.96B | $16.83B | $13.77B | $16.88B | $13.52B | $13.95B | $13.17B | $13.34B | $12.23B | $12.13B | · | $15.08B | $9.87B | $10.78B | · | $9.99B | |
| Current Liabilities | $40.76B | $40.05B | $36.70B | $40.63B | $36.79B | $37.14B | $34.26B | $34.06B | $32.73B | $32.78B | · | $36.85B | $31.31B | $32.86B | · | $31.33B | |
| Capital Leases | · | · | $615M | · | · | · | $738M | · | · | · | · | $936M | $3.17B | $3.14B | · | $3.04B | |
| Deferred Tax | $756M | $744M | $833M | $810M | $651M | $708M | $684M | $769M | $665M | $734M | · | $577M | $495M | $522M | · | $480M | |
| Other Non-current Liabilities | $2.81B | $2.55B | $1.81B | $2.05B | $3.90B | $2.87B | $2.57B | $2.62B | $4.77B | $4.16B | · | $3.65B | $7.37B | $6.19B | · | $5.68B | |
| Total Liabilities | $60.35B | $59.65B | $56.69B | $61.03B | $58.89B | $59.02B | $55.94B | $54.94B | $55.68B | $55.56B | · | $58.97B | $57.07B | $57.80B | · | $55.57B | |
| Long-term Debt | $16.11B | $16.37B | $17.49B | $17.58B | $17.58B | $18.32B | $18.53B | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Total Debt | $16.11B | $16.37B | · | $17.58B | $17.58B | $18.32B | · | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $11.31B | $10.21B | $8.67B | $9.78B | $16.41B | $16.66B | $15.35B | $15.06B | $14.35B | $13.21B | · | $12.00B | $11.53B | $10.47B | · | $9.55B | |
| Treasury Stock | $9.44B | $9.44B | $9.44B | $9.44B | $9.44B | $9.04B | $9.00B | $8.05B | $6.82B | $6.01B | · | $5.83B | $5.04B | $4.64B | · | $2.56B | |
| AOCI | $-194M | $-171M | $-58M | $-100M | $-231M | $-337M | $-504M | $-226M | $-646M | $-630M | · | $-1.12B | $-998M | $-915M | · | $-1.39B | |
| Stockholders' Equity | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | $27.92B | $26.41B | $27.31B | $27.35B | $26.96B | · | $25.30B | $25.67B | $25.04B | · | $25.38B | |
| Liabilities + Equity | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Shares Outstanding | 493,987,000 | 493,771,000 | 491,757,000 | 491,414,000 | 491,128,000 | 497,518,000 | 495,907,000 | 510,078,000 | 526,001,000 | 536,383,000 | 615,291,000 | 534,596,000 | 546,003,000 | 551,714,000 | 607,847,000 | 570,091,000 |
现金流 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $300M | $300M | $329M | $317M | $315M | $314M | $314M | $313M | $306M | $308M | $315M | $328M | $304M | $325M | $351M | $292M | |
| Stock-based Comp | $59M | $67M | $58M | $52M | $35M | $59M | $31M | $49M | $62M | $70M | $49M | $50M | $56M | $61M | $54M | $51M | |
| Deferred Tax | $19M | $-53M | $-73M | $129M | $-89M | $-27M | $-1M | $-26M | $-64M | $104M | $-92M | $174M | $-1M | $-159M | $51M | $-265M | |
| Amort. of Intangibles | $161M | $166M | $169M | $170M | $173M | $173M | $173M | $173M | $173M | $173M | $176M | $180M | $179M | $183M | $208M | $211M | |
| Operating Cash Flow | $3.59B | $4.37B | $437M | $1.36B | $1.78B | $1.51B | $-587M | $-978M | $2.17B | $-456M | $217M | $1.02B | $2.55B | $4.27B | $-1.58B | $3.33B | |
| CapEx | $174M | $200M | $213M | $211M | $208M | $135M | $154M | $153M | $186M | $151M | $223M | $136M | $215M | $225M | $233M | $247M | |
| Investing Cash Flow | $-353M | $89M | $660M | $1.24B | $-899M | $-529M | $102M | $-839M | $-1.17B | $852M | $-949M | $435M | $-424M | $-253M | $221M | $3M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $750M | $950M | $0 | $0 | $350M | $165M | $889M | $994M | $287M | $3M | $26M | |
| Net Debt Issued | · | $-1.05B | · | · | · | $-208M | · | · | · | $163M | · | · | · | $287M | · | · | |
| Stock Issued | $8M | $10M | $8M | $11M | $8M | $10M | $9M | $12M | $11M | $14M | $12M | $11M | $21M | $12M | $8M | $24M | |
| Stock Repurchased | $4M | $29M | $2M | $0 | $432M | $41M | $943M | $1.23B | $803M | $151M | $31M | $774M | $405M | $423M | $1.43B | $1.24B | |
| Net Stock Activity | · | $-19M | · | · | · | $-31M | · | · | · | $-137M | · | · | · | $-423M | · | · | |
| Financing Cash Flow | $-259M | $-1.06B | $-187M | $-10M | $-1.17B | $-250M | $-13M | $-1.25B | $-1.17B | $23M | $-201M | $-524M | $-750M | $-183M | $-1.73B | $-1.48B | |
| Net Change in Cash | $2.98B | $3.39B | $910M | $2.59B | $-288M | $731M | $-497M | $-3.06B | $-162M | $425M | $-984M | $958M | $1.36B | $3.83B | $-3.06B | $1.83B | |
| Taxes Paid | $-206M | $-19M | $-92M | $36M | $497M | $7M | $181M | $211M | $538M | $13M | $128M | $167M | $581M | $11M | $750M | $37M | |
| Free Cash Flow | · | $4.17B | · | · | · | $1.38B | · | · | · | $-607M | · | · | · | $4.04B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-747M | · | · | · | $3.90B | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.6% | 11.3% | · | 6.7% | 6.2% | 11.3% | · | 9.5% | 11.4% | 11.7% | · | 12.2% | 12.3% | 11.9% | · | · | |
| Operating Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| Net Margin | 2.0% | 3.1% | · | -13.3% | -0.52% | 2.8% | · | 1.7% | 2.9% | 2.9% | · | 1.2% | 2.8% | 2.9% | · | 2.1% | |
| Pretax Margin | 2.8% | 4.2% | · | -13.4% | -0.53% | 3.8% | · | 2.2% | 3.8% | 3.6% | · | 2.0% | 3.8% | 3.6% | · | 2.8% | |
| EBITDA Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| ROA | 1.3% | 1.8% | · | -8.1% | -0.30% | 1.6% | · | 0.86% | 1.4% | 1.4% | · | 0.57% | 1.3% | 1.4% | · | 0.93% | |
| ROE | 4.4% | 6.2% | · | -27.5% | -0.92% | 4.8% | · | 2.7% | 4.3% | 4.5% | · | 1.8% | 4.1% | 4.3% | · | 2.9% | |
| ROIC | 2.3% | 3.6% | · | -17.9% | -1.0% | 2.5% | · | 1.1% | 2.1% | 1.9% | · | 1.1% | 2.0% | 2.3% | · | 0.80% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | |
| Quick Ratio | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 6.2 | · | 4.1 | 6.5 | 6.8 | · | 2.8 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.96B | $195.00B | · | $187.07B | $177.22B | $168.89B | · | $160.31B | $155.89B | $154.95B | · | $150.40B | $148.30B | $147.88B | · | $141.39B | |
| Net Income TTM | $-4.25B | $-4.03B | · | $-4.86B | $2.92B | $4.33B | · | $3.49B | $3.84B | $3.82B | · | $3.40B | $2.75B | $2.54B | · | $2.00B | |
| Market Cap | $31.71B | $16.17B | · | $17.53B | $26.66B | $30.20B | · | $38.40B | $34.87B | $42.10B | · | $36.82B | $36.83B | $34.87B | · | $44.36B | |
| Enterprise Value | $20.76B | $8.80B | · | $15.88B | $26.95B | $31.24B | · | $38.43B | $32.29B | $40.43B | · | $34.39B | $35.45B | $35.21B | · | $45.51B | |
| P/E | -7.4 | -4.0 | · | -3.6 | 9.6 | 7.3 | · | 11.5 | 9.3 | 11.2 | · | 11.3 | 13.7 | 14.2 | · | 22.8 | |
| P/S | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| P/B | 1.4 | 0.8 | · | 0.8 | 1.0 | 1.1 | · | 1.4 | 1.3 | 1.6 | · | 1.5 | 1.4 | 1.4 | · | 1.7 | |
| P / Tangible Book | 4.2 | 2.6 | · | 3.3 | 5.5 | 5.9 | · | 9.2 | 8.6 | 12.1 | · | 25.2 | 84.7 | · | · | · | |
| P / Cash Flow | · | 3.7 | · | · | · | 20.0 | · | · | · | -92.3 | · | · | · | 8.2 | · | · | |
| P / FCF | · | 3.9 | · | · | · | 22.0 | · | · | · | -69.3 | · | · | · | 8.6 | · | · | |
| EV / EBITDA | 17.3 | 4.7 | · | -2.3 | -58.9 | 20.4 | · | 57.8 | 26.3 | 36.6 | · | 46.8 | 30.3 | 28.9 | · | 95.6 | |
| EV / FCF | · | 2.1 | · | · | · | 22.7 | · | · | · | -66.6 | · | · | · | 8.7 | · | · | |
| EV / Revenue | 0.1 | 0.0 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Earnings Yield | -13.6% | -25.3% | · | -28.1% | 10.4% | 13.7% | · | 8.7% | 10.7% | 8.9% | · | 8.9% | 7.3% | 7.1% | · | 4.4% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| 毛利率 % | 7.3% | 10.5% | 11.5% | — | — |
| 营业利润率 % | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% |
| 净收入 | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| 稀释后每股收益 (EPS) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 |
| 流动比率 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| 速动比率 | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $4.32B | $-490M | $7.25B | $5.26B | $3.29B |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 1122 家申报者 · $20.6B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 237 (+116 与上一季度对比) | 74 (-55 与上一季度对比) | 347 (+52 与上一季度对比) | 324 (-37 与上一季度对比) | +21.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2020581807 | 31478140 | 9.80% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1434820070 | 22352704 | 6.96% | 股份 |
| STATE STREET CORP | $1409957100 | 21965370 | 6.84% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $836741748 | 13035391 | 4.06% | 股份 |
| AMERIPRISE FINANCIAL INC | $788928731 | 12277112 | 3.83% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $754901345 | 11765825 | 3.66% | 股份 |
| HARRIS ASSOCIATES L P | $714090642 | 11124640 | 3.46% | 股份 |
| NORGES BANK | $491166346 | 7651758 | 2.38% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $478360377 | 7452257 | 2.32% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $407480559 | 6348038 | 1.98% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $366680625 | 5712426 | 1.78% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $314595190 | 4901000 | 1.53% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $290158057 | 4520300 | 1.41% | 买入期权 |
| Assenagon Asset Management S.A. | $238531902 | 3716029 | 1.16% | 股份 |
| EARNEST PARTNERS LLC | $227030787 | 3536856 | 1.10% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $219279973 | 3416108 | 1.06% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $197821063 | 3081805 | 0.96% | 股份 |
| 8 KNOTS MANAGEMENT, LLC | $193662188 | 4706250 | 0.94% | 股份 |
| Robeco Institutional Asset Management B.V. | $176439634 | 2748709 | 0.86% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $170815325 | 2661089 | 0.83% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $170810874 | 2661020 | 0.83% | 股份 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $164395918 | 2561083 | 0.80% | 股份 |
| JANE STREET GROUP, LLC | $161149958 | 2510515 | 0.78% | 股份 |
| LYRICAL ASSET MANAGEMENT LP | $157262740 | 2449957 | 0.76% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $156896112 | 2444246 | 0.76% | 股份 |
| JANE STREET GROUP, LLC | $150243114 | 2340600 | 0.73% | 买入期权 |
| RENAISSANCE TECHNOLOGIES LLC | $140730926 | 2192412 | 0.68% | 股份 |
| Politan Capital Management LP | $137059130 | 2135210 | 0.67% | 股份 |
| CITADEL ADVISORS LLC | $135787526 | 2115400 | 0.66% | 买入期权 |
| Qube Research & Technologies Ltd | $131408741 | 2047184 | 0.64% | 股份 |
| Quantinno Capital Management LP | $126343727 | 1968277 | 0.61% | 股份 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $121065870 | 1886055 | 0.59% | 股份 |
| Scharf Investments, LLC | $105948709 | 1650542 | 0.51% | 股份 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104240580 | 1623938 | 0.51% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $102119807 | 1590899 | 0.50% | 股份 |
| Ninety One UK Ltd | $97040208 | 1511766 | 0.47% | 股份 |
| BlackRock, Inc. | $96995070 | 1511062 | 0.47% | 股份 |
| IEQ CAPITAL, LLC | $94667113 | 1474796 | 0.46% | 股份 |
| Long Focus Capital Management, LLC | $93075500 | 1450000 | 0.45% | 股份 |
| Caisse de depot et placement du Quebec | $90440436 | 1408949 | 0.44% | 股份 |
| TWO SIGMA ADVISERS, LP | $90393876 | 2196692 | 0.44% | 股份 |
| Walleye Trading LLC | $89769715 | 1398500 | 0.44% | 买入期权 |
| Swiss National Bank | $89039490 | 1387124 | 0.43% | 股份 |
| Maple Rock Capital Partners Inc. | $88702813 | 1381879 | 0.43% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $88037805 | 1371519 | 0.43% | 股份 |
| Capital World Investors | $85968319 | 1339279 | 0.42% | 股份 |
| ROYAL BANK OF CANADA | $83731000 | 1304424 | 0.41% | 股份 |
| FMR LLC | $82642699 | 1287470 | 0.40% | 股份 |
| Legal & General Group Plc | $82580180 | 1286496 | 0.40% | 股份 |
| GOLDMAN SACHS GROUP INC | $81658346 | 1272135 | 0.40% | 股份 |
| Swedbank AB | $81278855 | 1266223 | 0.39% | 股份 |
| BANK OF AMERICA CORP /DE/ | $81231546 | 1265486 | 0.39% | 股份 |
| BANK OF MONTREAL /CAN/ | $75731362 | 1179800 | 0.37% | 卖出期权 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $74883027 | 1166584 | 0.36% | 股份 |
| Focused Investors LLC | $71748372 | 1117750 | 0.35% | 股份 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $69539402 | 1083337 | 0.34% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $69328795 | 1080056 | 0.34% | 股份 |
| Vanguard Global Advisers, LLC | $67731876 | 1055178 | 0.33% | 股份 |
| CAXTON ASSOCIATES LP | $66708455 | 1101163 | 0.32% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $65768946 | 1024598 | 0.32% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65005213 | 1012700 | 0.32% | 卖出期权 |
| RHUMBLINE ADVISERS | $64689517 | 1007784 | 0.31% | 股份 |
| Korea Investment CORP | $64394509 | 1003186 | 0.31% | 股份 |
| Walleye Trading LLC | $63084520 | 982778 | 0.31% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $61600511 | 959659 | 0.30% | 股份 |
| National Pension Service | $60317674 | 939674 | 0.29% | 股份 |
| JANE STREET GROUP, LLC | $58470671 | 910900 | 0.28% | 卖出期权 |
| CITADEL ADVISORS LLC | $57584849 | 897100 | 0.28% | 卖出期权 |
| Vinva Investment Management Ltd | $57411190 | 885450 | 0.28% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $54527351 | 849468 | 0.26% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $53459229 | 832828 | 0.26% | 股份 |
| BANK OF NOVA SCOTIA | $53046262 | 826395 | 0.26% | 股份 |
| California Public Employees Retirement System | $52789535 | 822395 | 0.26% | 股份 |
| Gotham Asset Management, LLC | $51174579 | 797236 | 0.25% | 股份 |
| Pine Valley Investments Ltd Liability Co | $49047579 | 764100 | 0.24% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $48416284 | 754265 | 0.23% | 股份 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46947683 | 730827 | 0.23% | 股份 |
| Cresset Asset Management, LLC | $46069740 | 717709 | 0.22% | 股份 |
| Walleye Trading LLC | $45581319 | 710100 | 0.22% | 卖出期权 |
| PRUDENTIAL FINANCIAL INC | $44480846 | 692956 | 0.22% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44054239 | 686310 | 0.21% | 股份 |
| Point72 Asset Management, L.P. | $43807685 | 682469 | 0.21% | 股份 |
| CAMBIAR INVESTORS LLC | $43472742 | 677251 | 0.21% | 股份 |
| Kopernik Global Investors, LLC | $41512700 | 646716 | 0.20% | 股份 |
| D. E. Shaw & Co., Inc. | $41248494 | 642600 | 0.20% | 卖出期权 |
| BARCLAYS PLC | $40106039 | 624802 | 0.19% | 股份 |
| Alberta Investment Management Corp | $38514000 | 600000 | 0.19% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $37494278 | 584114 | 0.18% | 股份 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $37459914 | 618349 | 0.18% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $36941345 | 575500 | 0.18% | 买入期权 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $36392328 | 566947 | 0.18% | 股份 |
| Pictet Asset Management Holding SA | $35261300 | 549327 | 0.17% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $33902270 | 528155 | 0.16% | 股份 |
| VANGUARD GROUP INC | $33224057 | 807389 | 0.16% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $30879877 | 943185 | 0.15% | 股份 |
| MACKENZIE FINANCIAL CORP | $30726084 | 478674 | 0.15% | 股份 |
| IMC-Chicago, LLC | $30548920 | 475914 | 0.15% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $30455395 | 474457 | 0.15% | 股份 |
| Polar Capital Holdings Plc | $30274251 | 471635 | 0.15% | 股份 |
| JONES FINANCIAL COMPANIES LLLP | $29598153 | 450299 | 0.14% | 股份 |
公司内部人士 77 位内幕人士 · 48 位高管 · 30 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Sarah London | Chief Executive Officer | 2026年3月15日 F | 1188831 | 0 | 0 | $0 |
| David P Thomas | CEO, Markets and Medicaid | 2023年12月15日 F | 132941 | 0 | 0 | $0 |
| NEIDORFF MICHAEL F | Chairman & CEO | 2021年12月15日 A | 6517610 | 0 | 0 | $0 |
| Andrew Lynn Asher | Chief Financial Officer | 2026年3月15日 F | 747989 | 0 | 0 | $0 |
| William Scheffel | Exec VP, CFO & Treasurer | 2016年3月1日 F | 138362 | 0 | 0 | $0 |
| Michael A Carson | Group President, Medicare&Spec | 2026年5月29日 I | — | 0 | 0 | $0 |
| Kenneth J Fasola | President | 2024年7月4日 F | 286066 | 0 | 0 | $0 |
| Susan Raye Smith | Chief Operating Officer | 2026年6月15日 F | 212237 | 0 | 0 | $0 |
| James E Murray | EVP, Chief Operating Officer | 2023年6月23日 A | 202853 | 0 | 0 | $0 |
| Christopher Koster | Secretary & General Counsel | 2026年8月18日 S | 305354 | 0 | 1 | $-3111332 |
| Tanya M Mcnally | Chief People Officer | 2026年4月15日 F | 127258 | 0 | 0 | $0 |
| Katie Casso | Corporate Controller & CAO | 2026年3月15日 F | 109776 | 0 | 0 | $0 |
| Colin A Toney | EVP, Mergers & Acquisitions | 2022年9月16日 A | 52123 | 0 | 0 | $0 |
| Mark J Brooks | EVP, Chief Information Officer | 2022年9月16日 A | 153755 | 0 | 0 | $0 |
| Shannon Bagley | EVP, Chief Admin. Officer | 2022年8月16日 F | 116705 | 0 | 0 | $0 |
| Brandy Burkhalter | EVP | 2022年3月24日 F | 350475 | 0 | 0 | $0 |
| Jesse N Hunter | EVP, M&A & Chief Strategy Ofcr | 2021年6月11日 S | 411792 | 0 | 0 | $0 |
| Jeffrey A. Schwaneke | EVP, HealthCare Enterprises | 2021年5月7日 S | 454549 | 0 | 0 | $0 |
| Christopher R Isaak | SVP, Corporate Controller, CAO | 2020年12月15日 F | 13630 | 0 | 0 | $0 |
| Keith H Williamson | EVP, Secr. & General Counsel | 2020年2月4日 F | 174049 | 0 | 0 | $0 |
| Christopher D Bowers | EVP, Markets | 2019年7月22日 A | 131492 | 0 | 0 | $0 |
| Cynthia J Brinkley | EVP, Chief Admin/Markets Offcr | 2019年2月5日 F | 300582 | 0 | 0 | $0 |
| Kenneth Rone Baldwin | EVP, Markets | 2016年12月15日 F | 92712 | 0 | 0 | $0 |
| Carol Goldman | Exec VP Chief Admin Officer | 2016年12月15日 F | 70876 | 0 | 0 | $0 |
| Donald G Imholz | EVP, Operations and CIO | 2015年12月11日 G | 151599 | 0 | 0 | $0 |
| David C Minifie | CMO, EVP Corporate Strategy | 2015年2月3日 F | 24031 | 0 | 0 | $0 |
| Robert T Hitchcock | EVP Health Plans | 2015年2月3日 F | 26415 | 0 | 0 | $0 |
| Edmund E Kroll | SVP Fin & Investor Relations | 2015年2月3日 F | 46279 | 0 | 0 | $0 |
| HARROLD JASON M | EVP, Specialty Comp. Bus. Unit | 2015年2月3日 F | 44329 | 0 | 0 | $0 |
| Karen Bedell | SVP Business Liaison | 2012年12月14日 F | 46819 | 0 | 0 | $0 |
| Mary V Mason | SVP & Chief Medical Officer | 2012年12月14日 F | 38974 | 0 | 0 | $0 |
| Mark W Eggert | Executive VP, Health Plans | 2012年2月14日 M | 103712 | 0 | 0 | $0 |
| Antonette Simonetti | SVP, Public Affairs | 2010年12月14日 F | 13377 | 0 | 0 | $0 |
| Frederick J Manning | Executive Vice President | 2010年12月14日 F | 20579 | 0 | 0 | $0 |
| Cary Hobbs | SVP, Bus Mgmt & Integration | 2009年12月16日 M | 20768 | 0 | 0 | $0 |
| Eric Slusser | Executive VP of Internat'l Dev | 2009年10月16日 A | 51754 | 0 | 0 | $0 |
| Patti Darnley | Sr. VP of Operations | 2007年12月14日 A | 14188 | 0 | 0 | $0 |
| Marie J Glancy | SVP, Oper Svcs & Reg Affairs | 2007年12月14日 A | 12362 | 0 | 0 | $0 |
| Per J Brodin | SVP, Chief Acctg Officer | 2007年12月12日 A | 13337 | 0 | 0 | $0 |
| Glendon A Schuster | Senior VP and CIO | 2006年12月12日 A | — | 0 | 0 | $0 |
| Lisa M Wilson | Sr. VP Investor Relations | 2006年12月12日 A | 18400 | 0 | 0 | $0 |
| Karey L Witty | SVP, Health Plan Business Unit | 2006年12月12日 A | 57500 | 0 | 0 | $0 |
| Joseph P Drozda JR | Sr. VP & Chief Medical Officer | 2006年12月12日 A | 32181 | 0 | 0 | $0 |
| James D Donovan JR | Senior VP Health Plans | 2005年12月13日 A | 3219 | 0 | 0 | $0 |
| Brian G Spanel | Sr Vice President, Development | 2005年6月24日 M | 186446 | 0 | 0 | $0 |
| Dan Paquin | Sr. VP New Plan Implementation | 2005年2月10日 M | 0 | 0 | 0 | $0 |
| John Tadich | Senior VP, Specialty Companies | 2004年12月1日 M | 0 | 0 | 0 | $0 |
| Catherine M Halverson | Senior VP Business Development | 2004年1月16日 | 0 | 0 | 0 | $0 |
| Paul J Diaz | 董事 | 2026年7月28日 A | 2771 | 0 | 0 | $0 |
| Lauren M Tyler | 董事 | 2026年7月17日 A | 3216 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 183 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| CAMX · ADVISORS' INNER CIRCLE FUND | 3.57% | 44000 NS | 2026年4月30日 | N-PORT |
| SMRI · EA Series Trust | 3.05% | 307327 NS | 2026年4月30日 | N-PORT |
| SRHQ · Elevation Series Trust | 1.96% | 70588 NS | 2026年4月30日 | N-PORT |
| RUNN · Strategic Trust | 1.87% | 108380 NS | 2026年5月31日 | N-PORT |
| EPMB · Harbor ETF Trust | 1.51% | 1264 NS | 2026年4月30日 | N-PORT |
| EPMV · Harbor ETF Trust | 1.40% | 1157 NS | 2026年4月30日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 1.32% | 2739 NS | 2026年4月30日 | N-PORT |
| EPSB · Harbor ETF Trust | 1.29% | 1122 NS | 2026年4月30日 | N-PORT |
| ABCS · EA Series Trust | 1.12% | 2127 NS | 2026年5月29日 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 1.01% | 105126 NS | 2026年5月31日 | N-PORT |
| HWSM · HOTCHKIS & WILEY FUNDS /DE/ | 0.94% | 403 NS | 2026年6月30日 | N-PORT |
| RILA · Spinnaker ETF Series | 0.92% | 7203 NS | 2026年4月30日 | N-PORT |
| SPXD · DBX ETF Trust | 0.75% | 856 NS | 2026年5月31日 | N-PORT |
| WLDR · Two Roads Shared Trust | 0.74% | 9894 NS | 2026年4月30日 | N-PORT |
| ITAN · EA Series Trust | 0.66% | 9949 NS | 2026年5月29日 | N-PORT |
| CLSE · Trust for Professional Managers | 0.64% | 66218 NS | 2026年5月31日 | N-PORT |
| INFO · Harbor ETF Trust | 0.63% | 90872 NS | 2026年4月30日 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.62% | 139637 NS | 2026年4月30日 | N-PORT |
| QIDX · Spinnaker ETF Series | 0.53% | 3779 NS | 2026年4月30日 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.52% | 1263251 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.48% | 819 NS | 2026年5月31日 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.44% | 942740 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.43% | 226652 NS | 2026年4月30日 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.43% | 1819403 NS | 2026年5月31日 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0.41% | 173542 NS | 2026年4月30日 | N-PORT |
| RXL · ProShares Trust | 0.40% | 4871 NS | 2026年5月31日 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.40% | 27252 NS | 2026年5月31日 | N-PORT |
| REVS · Columbia ETF Trust I | 0.40% | 21013 NS | 2026年4月30日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.39% | 85952 NS | 2026年5月31日 | N-PORT |
| CGGO · Capital Group Global Growth Equit... | 0.38% | 728871 NS | 2026年5月31日 | N-PORT |
| COPY · RBB Fund Trust | 0.36% | 21043 NS | 2026年5月31日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.36% | 9315 NS | 2026年4月30日 | N-PORT |
| CSM · ProShares Trust | 0.29% | 25742 NS | 2026年5月31日 | N-PORT |
| SGLC · RBB Fund, Inc. | 0.29% | 9437 NS | 2026年5月31日 | N-PORT |
| QLC · FlexShares Trust | 0.22% | 37380 NS | 2026年4月30日 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0.22% | 64885 NS | 2026年5月31日 | N-PORT |
| PALC · Pacer Funds Trust | 0.21% | 9061 NS | 2026年4月30日 | N-PORT |
| RECS · Columbia ETF Trust I | 0.21% | 211299 NS | 2026年4月30日 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund ... | 0.17% | 18802 NS | 2026年5月31日 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund ... | 0.17% | 23352 NS | 2026年4月30日 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 0.17% | 9673 NS | 2026年5月31日 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.16% | 34733 NS | 2026年5月31日 | N-PORT |
| GSLC · Goldman Sachs ETF Trust | 0.16% | 425518 NS | 2026年5月31日 | N-PORT |
| BRCE · MFS Active Exchange Traded Funds ... | 0.15% | 832 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.14% | 318708 NS | 2026年5月31日 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.13% | 10203 NS | 2026年5月31日 | N-PORT |
| QARP · DBX ETF Trust | 0.13% | 1636 NS | 2026年5月29日 | N-PORT |
| VEGN · ETF Series Solutions | 0.09% | 2740 NS | 2026年4月30日 | N-PORT |
| SCHV · SCHWAB STRATEGIC TRUST | 0.09% | 235026 NS | 2026年5月31日 | N-PORT |
| GLOV · Goldman Sachs ETF Trust | 0.09% | 25143 NS | 2026年5月31日 | N-PORT |